{
  "@context": "aku-v2",
  "@type": "genetics",
  "@id": "vasc:eds:col3a1-mutations",
  "metadata": {
    "version": "2.0.0",
    "created": "2026-01-07T03:16:00.000Z",
    "updated": "2026-01-07T03:16:00.000Z",
    "contributors": ["knowledge-graph-agent"],
    "confidence": 0.92,
    "status": "pending-quality-check"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/genetic-disorders",
    "type": "molecular-genetics",
    "difficulty": "advanced",
    "importance": "high"
  },
  "content": {
    "title": "COL3A1 Mutations in Vascular EDS",
    "description": "Molecular genetics of type III collagen mutations causing vascular Ehlers-Danlos syndrome",
    "key_concepts": [
      {
        "concept": "Gene Location",
        "details": "COL3A1 gene located on chromosome 2q32.2 encoding type III collagen"
      },
      {
        "concept": "Mutation Types",
        "details": "Glycine substitutions in triple helix domain most common; also splicing mutations and null alleles"
      },
      {
        "concept": "Genotype-Phenotype",
        "details": "Glycine substitutions generally cause more severe phenotype than haploinsufficiency variants"
      },
      {
        "concept": "Testing",
        "details": "Sequence analysis of COL3A1; consider deletion/duplication analysis if sequencing negative"
      }
    ],
    "clinical_significance": "Identifying specific mutations helps prognostication and family screening"
  },
  "provenance": {
    "primary_sources": ["Pepin M et al. Genet Med 2014"]
  }
}
